Tracking Clinical Trial Data at Scale
1,424
Linkages Identified
727
Entities Resolved
357
Source Revisions Tracked
A global life sciences organization partnered with iMerit to build and monitor public clinical trial data across sponsors and products.
Challenge
The organization needed an ongoing view of clinical trial activity across products and sponsors, but public data was fragmented across registries, sponsor pages, regulatory sources, and trial documents. Each source published on its own schedule and in its own format, making changes in trial status, phase, enrollment, or sponsorship difficult to track consistently. A small internal team was checking sources manually, with no reliable revision history and no scalable way to reconcile the same trial across multiple sources. As coverage expanded, the process could not keep pace. The client needed a partner that could build a monitoring capability from the ground up, preserve what changed over time, resolve records across sources, and route uncertain data for expert review before it reached stakeholders.
“We needed a partner who could track the market for us, not hand us a spreadsheet once a quarter.”
Solution
- Built the monitoring platform end to end, from source capture through validation and packaged delivery
- Created versioned source records so changes could be tracked over time instead of overwritten
- Resolved trials, sponsors, and products across sources using identifiers and similarity matching
- Applied confidence scoring and validation to surface uncertain or conflicting data
- Added human review for flagged extractions and candidate linkages before release
iMerit built the tool and workflow itself, turning the client’s tracking requirements into a recurring monitoring program. Public sources are captured using the appropriate method for each source, including structured APIs, web capture, and document ingestion, while each capture is stored as a timestamped version.
The platform then structures the data into two connected layers: versioned source records and the resolved trial, sponsor, and product entities built from them.
The same trial can appear differently across multiple sources, so the platform first uses shared identifiers to connect records and then applies similarity matching where identifiers are unavailable. Extracted fields receive confidence scores, and validation checks flag formatting, date, duplicate, and linkage issues.
Anything uncertain is routed to iMerit data specialists, who compare it with the original source and confirm or correct it before the dataset is packaged. This combination of automation and human review gives the client a repeatable way to track public market activity without rebuilding the process for every new sponsor, product, or registry.
Result
The platform replaced ad hoc manual tracking with a current, versioned view of public clinical trial activity.
Across the engagement, iMerit captured 282 source records through 357 revisions and resolved them into 727 trial, organization, and product entities connected by 1,424 explicit linkages.
The workflow also identified trials appearing across multiple registries and preserved a record of source changes over time.
The same platform and review team now support expansion beyond the initial products, giving the client a scalable foundation for monitoring additional sponsors and registries.
“iMerit consistently meets our quality bar and now tracks the market for us end to end.”
